Abstract
OptiMedica was founded in Silicon Valley in 2004 to deliver innovative ophthalmic technologies and transform existing standards of care in retina, glaucoma and cataract. Our breakthrough technologies include the PASCAL® (Pattern SCAnning Laser) family of photocoagulators for the treatment of retinal disease and glaucoma and the Catalys™ Precision Laser System for the treatment of cataract [1–4].